Morbidity and quality of life following cytoreduction and HIPEC.

M Deraco, D Baratti, S Kusamura
Author Information
  1. M Deraco: Department of Surgery, National Cancer Institute, Milano, Italy. marcello.deraco@istitutotumori.mi.it

Abstract

No abstract text available.

MeSH Term

Carcinoma
Chemotherapy, Cancer, Regional Perfusion
Combined Modality Therapy
Female
Humans
Hyperthermia, Induced
Infusions, Parenteral
Intestinal Diseases
Male
Minimally Invasive Surgical Procedures
Morbidity
Peritoneal Neoplasms
Postoperative Complications
Quality of Life
Survival Analysis

Word Cloud

Created with Highcharts 10.0.0MorbidityqualitylifefollowingcytoreductionHIPEC

Similar Articles

Cited By